Physician profile
Stephen Allen
NPI 1114992583
$910.94
in general payments reported to CMS, 2019-2025
24 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $38.30 · 2021: $85.41 · 2022: $80.96 · 2023: $105 · 2024: $191 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $158.54 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $93.60 | 2019-2025 | |
| Organon LLC | $81.85 | 2021-2024 | Nexplanon |
| Astellas Pharma US INC | $77.72 | 2023-2025 | Veozah |
| Amgen INC. | $70.12 | 2019 | |
| Pfizer INC. | $64.05 | 2024-2025 | |
| Exact Sciences Corporation | $51.10 | 2024-2025 | Cologuard Collection Kit |
| Minerva Surgical, INC | $39.27 | 2019-2023 | |
| Shield Therapeutics INC | $34.24 | 2024-2025 | |
| Coopersurgical, INC. | $29.28 | 2019 | |
| Exeltis, USA INC. | $23.53 | 2025 | Slynd |
| Therapeuticsmd, INC. | $22.44 | 2019 | |
| Scynexis, INC. | $18.34 | 2022 | |
| Conmed Corporation | $17.90 | 2025 | Visiclear, Airseal, Vcare |
| Heron Therapeutics, INC. | $14.84 | 2025 | Aponvie |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $14.50 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $14.41 | 2019 | |
| Hologic Sales and Service, LLC | $14.20 | 2024 | Acessa Provu System |
| Axonics, INC. | $13.78 | 2023 | Axonics |
| Allergan, INC. | $12.10 | 2020 | |
| Lupin INC. | $11.86 | 2019 | |
| Avion Pharmaceuticals | $11.46 | 2021 | |
| Coloplast Corp | $10.91 | 2019 | |
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.